Dear,
I'm Min Cong, the technical support from GeneMedi.
Here I want to share with you GeneMedi's COVID-19 Vaccine & Antibody Candidates Efficacy Evalution Solution for new variants of SARS-CoV-2
Information
Collection
|
UK-B.1.1.7
lineage
|
South Africa
501Y.V2
|
P.1 lineage
(B.1.1.28.1, Brazilian variant)
|
Others Variants |
|
Spike protein & ACE2 competition binding assay
(Full list of products→)
Human soluble ACE2 protein
|
Spike Protein RBD-N501Y mutant (Details→) |
Spike Protein RBD(K417N, E484K and N501Y mutant) (Details→) |
Spike Protein RBD(K417N, E484K and N501Y mutant) (Details→) |
Spike S6P trimer (F817P, A892P, A899P, A942P, K986P, V987P), V341I, F342L, F342L, V341I, F342L, N354D, D364Y, V367F, R408I, A435S, W436R, K458R, G476S, V483R, N protein (Details→) |
Spike S-trimer protein D614G mutant (Details→) |
Spike S-trimer protein D614G mutant (Details→) |
Spike Protein S1 D614G mutant (Details→) |
Spike Protein S1 D614G mutant (Details→) |
Spike Protein RBD-N501Y mutant (Details→) |
Spike Protein RBD-N501Y mutant (Details→) |
Spike Protein RBD-E484K mutant (Details→) |
Spike Protein RBD-E484K mutant (Details→) |
|
Multi-VariantsTM SARS-CoV2
Pseudovirus Neutralization Assay System
(Full list of products→)
293T-hACE2 stable cell line
|
RBD N501Y mutation (Details→) |
501Y.V2 RBD triple mutation (K417N, E484K and N501Y) Pseudovirus (Details→) |
RBD triple mutation(K417T, E484K and N501Y)+D614G Pseudovirus (Details→) |
S943P, V367F, G476S, V483A, H49Y, Q239, A831V, P1263L, D839Y/N/E-D839Y, D839Y/N/E-D839N, D839Y/N/E-D839E, P2-mutated Spike trimer (Details→) |
whole mutant B.1.1.7 Pseudovirus (Details→) |
whole mutant 501Y.V2 Pseudovirus (Details→) |
whole mutant Brazilian P.1 Pseudovirus (Details→) |
B.1.1.7-S1 HV 69-70 Deletion mutation SARS-CoV-2(2019nCoV) Pseudovirus (Details→) |
501Y.V2 E484K mutation Pseudovirus (Details→) |
501Y.V2 E484K mutation Pseudovirus (Details→) |
|
Spike S1 D614G mutation Pseudovirus (Details→) |
Spike S1 D614G mutation Pseudovirus (Details→) |
|
RBD N501Y mutation (Details→) |
RBD N501Y mutation (Details→) |
|
codon-optimized spike mammalian expression vector
(Full list of products→) |
RBD N501Y mutation (Details) |
pCDNA3.1 |
RBD triple mutation (501Y.V2 lineage) |
pCDNA3.1 |
RBD triple mutation (K417T, E484K and N501Y mutant)+D614G |
pCDNA3.1 |
viral vector & mammalian & E.coli Expression system: Spike mutation(D614G, S943P,V367F, G476S, V483A, H49Y, Q239K, A831V, P1263L, D839Y/N/E, D839Y, D839N, D839E), P2-mutated Spike trimer, N protein,S protein (Spike), RBD, D614G, E protein(Envelope), M protein, ORF1ab/3a/6/7/8/10, Nsp1-16, ACE2, TMPRSS2 (Details→) |
Pre-made adenovirus |
Pre-made adenovirus |
Pre-made adenovirus |
B.1.1.7 lineage whole mutation |
pCDNA3.1 |
501Y.V2 lineage whole mutation |
pCDNA3.1 |
P.1 lineage whole mutation |
pCDNA3.1 |
Pre-made adenovirus |
Pre-made adenovirus |
Pre-made adenovirus |
S1 HV 69-70 Deletion mutation(ΔH69/ΔV70,B.1.1.7 lineage) |
pCDNA3.1 |
E484K mutation(501Y.V2 lineage) |
pCDNA3.1 |
E484K mutation(501Y.V2 lineage) |
pCDNA3.1 |
Pre-made adenovirus |
Pre-made adenovirus |
Pre-made adenovirus |
|
RBD N501Y mutation(B.1.1.7 RBD) |
pCDNA3.1 |
RBD N501Y mutation(B.1.1.7 RBD) |
pCDNA3.1 |
Pre-made adenovirus |
Pre-made adenovirus |
D614G mutation |
pCDNA3.1 |
D614G mutation |
pCDNA3.1 |
D614G mutation |
pCDNA3.1 |
Pre-made adenovirus |
Pre-made adenovirus |
Pre-made adenovirus |
The products of Brazilian variants: (B.1.1.28.P1& B.1.1.28.P2) have been developed also and will be available on GeneMedi's COVID-19 products pages ASAP, which is also including:
1) Recombinant B.1.1.28 lineage Spike RBD variants protein (K417T, E484K, N501Y);
2) Pseudovirus of B.1.1.28 lineage;
3) Vectors of B.1.1.28 lineage
Protocol and information collection of COVID-19 vaccines, new variants: https://www.genemedi.net/i/covid19-drug-and-vaccine-discovery
Please let me know if there is any opportunity to be your supplier and collaborator in COVID-19 related products.
Should you have any questions or ideas please let me know.
Best regards,
Min Cong
Technical support from GeneMedi
Whatsapp ID:+86 18317083382
GeneMedi Biotechnology
Address: 2nd Floor, Building 21, No 518, Xinzhuan Road, Shanghai, China
Website: www.genemedi.net
unsubscribe
|